Article Details
Retrieved on: 2023-11-11 20:09:06
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The company could have launched Brenzavvy with a list price of about $500 and still undercut competitors like AstraZeneca PLC's (AZN) Farxiga and ...
Article found on: www.morningstar.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here